13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 15 managers

Reported value

$97.2M

Holders

15

+1 new · −1 exited

Holders’ est. mark

$20.8M

Price effect on 10 books still in the name

Largest holder

$32.6M

Alberta Investment Management Corp

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Alberta Investment Management Corp25M$32.6MHeld
BARCLAYS PLC1.36M$32.3M$16.3MAdded$3.77M
DANSKE BANK A/S55K$17.9M$2.98MAdded$3.57M
Swiss Life Asset Management Ltd23.8K$7.76M$550KAdded$5.11M
OP Asset Management Ltd13.9K$4.54M$767KAdded$850.1K
Sanctuary Advisors, LLC4.07K$1.33M$184.3KAdded$439.3K
NWAM LLC912$357.7KHeld
INDEPENDENT FINANCIAL GROUP, LLC635$207.1K$35.6KCut−$33.3K
VIRTUS ADVISERS, LLC47K$61.1K$6.93KAdded$6.93K
Prestige Wealth Management Group LLC184$60K$10.3KCut−$25.3K
ELEVATION POINT WEALTH PARTNERS, LLC113$36.8KNew
Essential Partners LLC62$20.2KHeld
Aventura Private Wealth, LLC40$13K$1.68KAdded$4.94K
Leonteq Securities AG29$9.46K$1.23KAdded$384

Who left

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.